Featured Research

from universities, journals, and other organizations

Patient referrals cause differences in hospital infection rates

Date:
March 19, 2010
Source:
Public Library of Science
Summary:
Patient referrals between hospitals influence the rates of hospital-acquired infections such as MRSA, according to a new study. The findings explain that referred patients, who have the potential to carry a hospital-acquired infection with them, are more likely to be admitted to University Medical Centers than to teaching or general hospitals.

Patient referrals between hospitals influence the rates of hospital-acquired infections such as MRSA, according to a study by researchers based in the Netherlands. The findings, published March 19 in the open-access journal PLoS Computational Biology, explain that referred patients, who have the potential to carry a hospital-acquired infection with them, are more likely to be admitted to University Medical Centers than to teaching or general hospitals.

The prevalence of hospital-acquired infection is widely believed to reflect the quality of hygiene and health care in individual hospitals, and is therefore often used as a benchmark for hospital quality. However, this assumes that the rate at which patients introduce infections is equal for all hospitals. The authors, from the National Institute for Public Health and the Environment, the University Medical Center Groningen, and the University Medical Center Utrecht, show that this assumption is unlikely to be correct.

The authors used patient admissions data, gathered from the National Medical Registry, to reconstruct the entire hospital network of the Netherlands. The University Medical Centers were shown to be central to this network as they admit more patients who have recently stayed in other hospitals. Therefore, the authors conclude, the University Medical Centers are more likely to admit patients that still carry pathogens acquired during previous hospital visits, thus raising their rates of hospital-acquired infections.

The authors show that this difference in connectedness within the network results in differences in prevalence of hospital-acquired infections by using an individual-based model. As a consequence the authors suggest that interventions should therefore focus on hospitals that are central in the network of patient referrals.

The authors note that their methods do not account for transmission outside the hospitals. If community transmission of hospital-acquired infections becomes a significant factor, the observed effect will be diluted.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Donker et al. Patient Referral Patterns and the Spread of Hospital-Acquired Infections through National Health Care Networks. PLoS Computational Biology, 2010; 6 (3): e1000715 DOI: 10.1371/journal.pcbi.1000715

Cite This Page:

Public Library of Science. "Patient referrals cause differences in hospital infection rates." ScienceDaily. ScienceDaily, 19 March 2010. <www.sciencedaily.com/releases/2010/03/100319085304.htm>.
Public Library of Science. (2010, March 19). Patient referrals cause differences in hospital infection rates. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/03/100319085304.htm
Public Library of Science. "Patient referrals cause differences in hospital infection rates." ScienceDaily. www.sciencedaily.com/releases/2010/03/100319085304.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins